Search Results

June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC

Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid “You can try, try, try—and fail, fail, fail,” Eric says. Instead of chasing linear progress, Eric encourages young scientists to stay playful longer—embracing Eric and his team rejected the calcium route entirely. Eric is clear: real innovation requires real partnerships.

Eric Trinquet, Director of Research and Development at Revvity.   Eric Trinquet  to the Dr. precision reagents and validated assay platforms. 🔍 Learn More → Listen to the Podcast with Revvity’s Eric

Biochemistry and Molecular Medicine and the CEO of the Institute for Research in Immunology and Cancer ( IRIC Michel Bouvier on the web Wikipedia IRIC Bouvier Lab Google Scholar Pubmed ResearchGate Twitter LinkedIn

Eric Trinquet discusses the science and story behind pH Sense, Revvity’s innovative GPCR internalization Eric Trinquet What does it take to design a breakthrough GPCR assay—from idea to industrial impact? Eric Trinquet shares the inside story behind the development of pH Sense, Revvity’s latest innovation decades at the intersection of fluorescence chemistry, functional assays, and product development, Eric Inside This Episode How Eric and his team reimagined rare earth complexes to develop pH-sensitive probes

Build Your GPCR Assay Workflow Meet the Team behind pHSense™ Eric TRINQUET Sr Director Life Sciences Reagents, Revvity Eric Trinquet is a recognized expert in the field of immunoassays and fluorescence Eric Trinquet, Director of Research and Development at Revvity. Related Articles How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs Discover Eric Trinquet. Dr.